<< CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses | Breastfeeding reduces a woman's risk of developing Metabolic Syndrome >>

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Published on December 3, 2009 at 8:52 AM · No Comments

Hyperion Therapeutics, Inc. today announced that the first patient has been enrolled in its phase II clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The multi-center study consists of an open label safety component followed by a randomized, double-blind, placebo-controlled study that will enroll approximately 140 patients with episodic hepatic encephalopathy in the US and Eastern Europe. The primary efficacy measure will be the proportion of patients who exhibit a hepatic encephalopathy episode during the four-month treatment period.

SOURCE Hyperion Therapeutics

3c4101cf-bb96-4552-8aea-ff1dfef9ef01|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Amenorrhea, Body Odor, Brain, Cirrhosis, Congestive Heart Failure, Edema, Encephalopathy, Gastroenterology, Haloperidol, Heart Failure, Hepatology, Hypersensitivity, Placebo, Valproic Acid

Related posts

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patientsCovidien, a leading global provider of healthcare products, today announced that the U.S. Food and D...
Montifiore's surgeons receive certification training for implanting total artificial heartA surgical team from the Montefiore Einstein Center for Heart and Vascular Care recently received ce...
Study: Low-carb diet greatly reduces liver fatCurbing carbohydrates is more effective than cutting calories for individuals who want to quickly re...
Updated Phase 1 study results of FOLOTYN in patients with refractory CTCL presented at ASH 2010Allos Therapeutics, Inc. today reported updated results from the Company's Phase 1 dose-finding stud...
HIV drugs lead to insulin resistanceThe same powerful drugs that have extended the lives of countless people with HIV come with a price ...
Functional MRI can be used to assess tumor viabilityPancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the...
Embryonic stem cells raise hope of cellular replacement therapy for liver failureEmbryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate in...
HD colonoscopy is more sensitive than standard colonoscopy in finding polyps: StudyHigh-definition (HD) colonoscopy is much more sensitive than standard colonoscopy in finding polyps ...
Mutations associated with prion diseases are sufficient to cause transmissible neurodegenerative diseaseFor the first time, Whitehead Institute researchers have shown definitively that mutations associate...
Jeffrey Friedman receives Shaw Prize for discovery of leptinJeffrey M. Friedman, Marilyn M. Simpson Professor and head of the Laboratory of Molecular Genetics a...
Antipsychotic drugs get FDA label changesThe U.S. Food and Drug Administration today exercised its new authority under the Food and Drug Admi...
Nasal spray effective for most severe kind of headacheA nasal spray is safe and effective at rapidly treating cluster headaches, which are considered to b...
Chewing gum which fights tooth decayConsumers will soon be able to buy a chewing gum which contains friendly bacteria which can help pre...
Study finds brain changes begin gradually in 'middle age'A study looking at brain function in young, middle-aged and older adults has identified changes in b...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.